CATALYST PHARMACEUTICALS: Next Big Thing on S&P SmallCap 600
Catalyst Pharmaceuticals Inc. (NASDAQ: CPRX), a commercial-stage biopharmaceutical company, is slated to replace ManTech International Corp. (NASDAQ: MANT) in the S&P SmallCap 600 before the opening of trading on Thursday, September 15. The company develops novel medicines for rare chronic neuromuscular and neurological diseases. Its main...
